Suchergebnisse - "71050168A2"

PubPharm (18)

1

Merging the Versatile Functionalities of Boronic Acid with Peptides

enthalten in: International journal of molecular sciences | 2021

von Tan, Y. | Wu, J. | Song, L. | +6

2

Pharmacology differences among proteasome inhibitors : Implications for their use in clinical practice

enthalten in: Pharmacological research | 2021

von Fogli, S. | Galimberti, S. | Gori, V. | +2

3

The Ubiquitin-Proteasome Pathway and Epigenetic Modifications in Cancer

enthalten in: Anti-cancer agents in medicinal chemistry | 2021

von Yerlikaya, A. | Kanbur, E. | Stanley, B. | +1

4

Maintenance therapy and need for cessation studies in multiple myeloma : Focus on the future

enthalten in: Best practice & research. Clinical haematology | 2020

von Diamond, B. | Maclachlan, K. | Chung, D. | +2

5

Proteasome Inhibitors : Harnessing Proteostasis to Combat Disease

enthalten in: Molecules (Basel, Switzerland) | 2020

von Sherman, D. | Li, J.

6

Immunoproteasome-selective inhibitors : An overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases

enthalten in: European journal of medicinal chemistry | 2019

von Xi, J. | Zhuang, R. | Kong, L. | +3

7

Next-generation proteasome inhibitors for cancer therapy

enthalten in: Translational research : the journal of laboratory and clinical medicine | 2018

von Park, J. | Miller, Z. | Jun, Y. | +2

8

Proteasome inhibitors for the treatment of multiple myeloma

enthalten in: Expert opinion on pharmacotherapy | 2018

von Scalzulli, E. | Grammatico, S. | Vozella, F. | +1

9

Role of novel proteasome inhibitors in the treatment of relapsed/refractory multiple myeloma

enthalten in: Rinsho ketsueki] The Japanese journal of clinical hematology | 2018

von Ri, M.

10

Proteasome inhibitors : structure and function

enthalten in: Seminars in oncology | 2017

von Nunes, A. | Annunziata, C.